ATP-Dependent Mineralization of Hyaline Articular Cartilage Matrix Vesicles

  • Robert L. Wortmann
  • Majeedul Chowdhury
  • John W. Rachow
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 253A)


Cartilage matrix vesicles are particulate structures found in the extracellular matrix of epiphyseal and articular cartilage (1). These membrane-bound particles of membranes contain enzyme activities including ATP pyrophosphohydrolase and 51 nucleotidase (Figure 1). Mineralization of matrix vesicles is believed to play an important role in cartilage calcification (1, 2). In some in vitro systems, the mineralization of matrix vesicles is an ATP-dependent process (3, 4). Adenosine deaminase (ADA) deficiency, an inborn error of metabolism that causes severe combined immunodeficiency disease, is associated with chondro-osseous dysplasia (5, 6). The chondro-osseous dysplasia is associated with radiographic and histologic evidence of abnormal calcification of growth plate cartilage (7, 8). The cause of the abnormal calcification is unknown. In vitro, a model of ADA deficiency is toxic to growth plate cartilage. The toxicity is associated with accumulatuion of deoxyATP but correlates with ATP depletion in chondrocytes (9). Studies were performed to understand the biochemistry of matrix vesicle mineralization and to test the hypothesis that the abnormal calcification observed in the chondro-osseous dysplasia of ADA deficiency is caused by abnormal matrix vesicle mineralization secondary to ATP depletion.


Matrix Vesicle Cartilage Calcification Basic Calcium Phosphate Growth Plate Cartilage Severe Combine Immunodeficiency Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Anderson, H.C.: Vesicles associated with calcification in the matrix of epiphyseal cartilage. J Cell Biol 41: 59–72, 1969.PubMedCrossRefGoogle Scholar
  2. 2.
    Ali, S.Y., Sajdera, S.W., and Anderson, H.C.: Isolation and characterization of calcifying matrix vesicles from epiphyseal cartilage. Proc Natl Acad Sci USA 67: 1513–1520, 1970.PubMedCrossRefGoogle Scholar
  3. 3.
    Hsu, H.H.T., and Anderson, H.C.: A simple and defined method to study calcificaiton by isolated matrix vesicles. Effect of ATP and vesicle phosphate. Biochem Biophys Acta 500: 162–172, 1977.PubMedCrossRefGoogle Scholar
  4. 4.
    Siegel, S.A., Hummel, C.F., and Carty, R.P.: The role of nucleoside triphosphate pyrophosphohydrolase in in vitro nucleoside triphosphate-dependent matrix vesicle calcifications. J Biol Chem 258: 8601111–8607, 1983.Google Scholar
  5. 5.
    Giblett, E.R., Anderson, J.E., Cohen, F., et al: Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity. Lancet 11: 1067–1069, 1972.CrossRefGoogle Scholar
  6. 6.
    Meuwissen, H.F., Pollara, B., and Pickering, R.F.: Combined immunodeficiency disease associated with adenosine deaminase deficiency. J Pediatr 86: 169–181, 1975.PubMedCrossRefGoogle Scholar
  7. 7.
    Wolfson, J.J. and Cross, V.F.: The radiographie findings in forty-nine patients with combined immunodeficiency. In Combined Immunodeficiency Disease and Adenosine Deaminase Deficiency: A Molecular Defect; Hilaire, Meuwissen, Pickering, Pollara, and Porter, Eds., pp 255–275, Academic Press, New York, 1975.Google Scholar
  8. 8.
    Cederbaum, S.D., Kaitila, I., Rimoin, D.L., and Stiehn, E.R.: The chondro-osseous dysplasia of adenosine deaminase deficiency with severe combined immunodeficiency. J Pediatr 89: 737–742, 1976.PubMedCrossRefGoogle Scholar
  9. 9.
    Wortmann, R.L., Veum, J.A. and Cheung, H.S.: Adenosine deaminase deficiency and chondro-osseous dysplasia. Adv Exp Biol Med 195A: 81–83, 1986.CrossRefGoogle Scholar
  10. 10.
    Ali, S.Y.: Matrix vesicles and apatite nodules in arthritic cartilage, Perspectives In Inflammation. Edited by D.A. Wulloughby, J.P. Giroud, and G.P. Velo. Baltimore, University Park Press, 1977, pp 211–223.Google Scholar
  11. 11.
    Einhorn, T.A., Gordon, S.L., Siegel, S.A., Hummel, C.F., Avitable, M.J. and Carty, R.P.: Matrix vesicle enzymes in human osteoarthritis. J Orthopaed Res 3: 160–169, 1985.CrossRefGoogle Scholar
  12. 12.
    Rachow, J.W. and Ryan, L.M.: Adenosine triphosphate pyrophosphohydrolase and neutral inorganic pyrophosphatase in pathologic joint fluids. Arthritis Rheum 28: 1283–1288, 1985.PubMedCrossRefGoogle Scholar
  13. 13.
    Rachow, J.W., Veum, J., and Wortmann, R.L: Synovial fluid 5′-nucleotidase activity in arthritic joints. Clin Res 35: 895A, 1987.Google Scholar
  14. 14.
    Rachow, J.W., Ryan, L.M., McCarty, D.J., and Halverson, P.C.: Synovial fluid inorganic pyrophosphate concentration and nucleotide pyrophosphohydrolase activity in basic calcium phosphate arthropathy and Milwaukee shoulder syndrome. Arthritis Rheum 231: 408–413, 1988.CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1989

Authors and Affiliations

  • Robert L. Wortmann
    • 1
  • Majeedul Chowdhury
    • 1
  • John W. Rachow
    • 1
  1. 1.Medical College of WisconsinVeterans Administration Medical CenterMilwaukeeUSA

Personalised recommendations